The conference call is set for Thursday, October 22, at 11:00 a.m. Mexico City time. Chief Executive Officer Marco Sparvieri, Chief Financial Officer Antonio Zamora, and Investor Relations Officer Christianne Ibanez will lead the discussion. Interested parties can access the session via a dedicated webcast, requiring prior registration to receive confirmation details.
Genomma Lab remains a significant player in the pharmaceutical and personal care markets, operating a business model centered on product development and retail distribution. The company trades on the Mexican Stock Exchange under the ticker LAB B.
Comments (0)
No comments yet. Be the first!